|
RPA2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.315000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.356000E-01 |
| Normal-vs-Stage2 |
8.347800E-01 |
| Normal-vs-Stage3 |
5.216800E-01 |
| Normal-vs-Stage4 |
5.992200E-01 |
| Stage1-vs-Stage2 |
9.643400E-01 |
| Stage1-vs-Stage3 |
6.966400E-01 |
| Stage1-vs-Stage4 |
7.954400E-01 |
| Stage2-vs-Stage3 |
7.595200E-01 |
| Stage2-vs-Stage4 |
8.108800E-01 |
| Stage3-vs-Stage4 |
9.967800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.549400E-01 |
| Normal-vs-AfricanAmerican |
9.354200E-01 |
| Normal-vs-Asian |
9.795600E-01 |
| Caucasian-vs-AfricanAmerican |
3.110600E-01 |
| Caucasian-vs-Asian |
7.515600E-01 |
| AfricanAmerican-vs-Asian |
9.883200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.273400E-01 |
| Normal-vs-Female |
8.889600E-02 |
| Male-vs-Female |
4.783500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.940000E-01 |
| Normal-vs-Extreme_Weight |
4.132800E-01 |
| Normal-vs-Obese |
2.450600E-01 |
| Normal-vs-Extreme_Obese |
5.643600E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.828400E-01 |
| Normal_Weight-vs-Obese |
4.205600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.618400E-02 |
| Extreme_Weight-vs-Obese |
6.937800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.503700E-02 |
| Obese-vs-Extreme_Obese |
2.885800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.339830E-01 |
| Normal-vs-Age(41-60Yrs) |
2.269400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.968200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.424600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.479400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.172640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.324640E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.239900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.482800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.268400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.551600E-01 |
| Normal-VS-Type2 PRCC |
2.682600E-01 |
| Normal-VS-KIRP CIMP |
6.14230000000049E-05 |
| Normal-VS-Unclassified PRCC |
7.315800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.443000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.807330E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.436400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.80789999982123E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
1.382030E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.790900E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.840400E-01 |
| Normal-vs-N1 |
4.045000E-01 |
| Normal-vs-N2 |
9.027600E-01 |
| N0-vs-N1 |
3.387000E-01 |
| N0-vs-N2 |
9.635600E-01 |
| N1-vs-N2 |
6.500800E-01 |
|
|
